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Prepregnancy Care: A Shared
Responsibility
T
he effective management of preg-
nancies complicated by diabetes is a
shared responsibility—an equal
partnership between health care profes-
sionals and a responsible woman. Over
the last 30 years, major advances in our
understanding of the pathophysiology
and care of diabetes has led to the hope
thatpregnancyoutcomesforwomenwith
diabeteswouldbesimilartotheoutcomes
for women without diabetes as stated in
the goal of the Saint Vincent’s Declaration
in 1989 (1). Unfortunately this has not
been realized with the risk of congenital
malformations, stillbirths, and neonatal
death remaining as high as 3–10 times
that of the background population (2–5).
For over a decade, major evidence-
basedguidelineshavecalledforthecoun-
selingofwomenofchild-bearingagewith
diabetes about the need for family plan-
ning and excellent control prior to con-
ception (6–9). Also, preconception care
provides the opportunity for the woman
and her health caregivers to evaluate nu-
tritionalneeds,thepresenceandextentof
any micro-/macrovascular complications,
and to adjust medications or diabetes
management plans before pregnancy
occurs.
Ideally, every woman with known di-
abeteswouldnotonlyhaveprepregnancy
counseling but actually receive effective
prepregnancy care. This has been an elu-
sive goal that is underlined in the article
by Murphy et al. (10) in this issue of Di-
abetes Care. These investigators devel-
oped a remarkable “marketing” plan,
which included a website, lively and en-
couraging pamphlets mailed directly to
potential patients, as well as local and
community educational activities for
health professionals. Disappointingly,
only 27% of the eligible women with pre-
gestationaldiabetesactuallypresentedfor
prepregnancy care. This mirrors similar
attempts in Maine (34%) using a state-
wide community–based educational pro-
gram for health providers and Ohio (37%
inthethird5-yearphaseofa15-yearpro-
gram) to optimize access and use of
prepregnancy counseling and care
(11,12).IntheOhiostudy,asinthestudy
by Murphy et al., improvement in
prepregnancycareequatedwithimprove-
ment in adverse pregnancy outcomes.
Thus, a care gap exists between “de-
sired” and “real” prepregnancy care. The
suggested reasons for this gap include so-
cioeconomic deprivation, ethnic differ-
ences in the risks and use of the health
care system, or difﬁculties with health lit-
eracy (3,13–15). Murphy et al. observed
that some women became pregnant faster
than expected after discontinuing contra-
ception or instituting lifestyle changes
and thus had not yet achieved optimal con-
trol or changed medications. Logistical and
ﬁnancial concerns also played roles as well
as previous negative relationships with
healthprofessionals.Therewasalsoafearof
disappointment or a desire for minimal
medical input to maximize positive preg-
nancy experiences (15,16).
Onlyabouthalfofwomenwithtype1
diabetes receive prepregnancy care with
littleevidenceofimprovedoutcomesover
the last 10 years (4,10). The normal glu-
cose values in pregnancy (mean A1C
5.3% and upper limit of normal under
5.7%) are achieved by few women, and
thegoalA1Cofunder6%remainselusive
(4,17). Achievement of this level of glu-
cose control without hypoglycemia re-
quires a truly expert and experienced
health care team and a highly motivated
and knowledgeable woman with type 1
diabetes. The signiﬁcant knowledge and
attention to detail needed concerning nu-
trition,insulinself-adjustment,anduseof
frequent glucose monitoring information
with frequent injections and/or pump
therapycanprovetobebeyondthewom-
an’s capabilities; others lack the needed
motivation to intensify their management
adequately. Indeed, such demands of
knowledge and motivational methods
may prove to be even beyond the abilities
of their team of health professionals. Not
all women will have access to adequately
experienced teams in specialized centers
who can work with them to achieve such
controlorfamilysupportintegraltoeffec-
tive self-care. Additionally, advanced
technologies such as continuous glucose
monitoring and pump therapy may be re-
quiredinordertosafelyachievesuchnor-
malglucoselevels,andthesetechnologies
may be unavailable for economic or prag-
maticreasonstomanywomenwithtype1
diabetes (18,19).
The prevalence of type 2 diabetes is
rising worldwide in women of childbear-
ing age, and their care is generally in the
hands of primary-care physicians (20).
Thus, fewer women with type 2 diabetes
relativetotype1diabetesareseeninmul-
tidisciplinary prepregnancy clinics and,
although most guidelines—including the
International Diabetes Federation’s
Global Diabetes in Pregnancy Guide-
line—recommend insulin as optimal
therapy ideally initiated prior to preg-
nancy, the reality is that this is often not
done (3,7,10,13). A recent review of ma-
ternal and fetal outcomes in type 1 and
type 2 diabetic women suggests that, al-
though women with type 2 diabetes gen-
erally have had the disease for a shorter
period of time, have and can achieve bet-
ter glucose control in the pregnancy, and
have lower rates of diabetes complica-
tions, they have equally poor outcomes
(21).Yetwomenwithtype2diabeteswho
access prepregnancy care can safely
achieve normal glycemia in pregnancy
with much less effort, as discussed in a
recent review (22).
Interestingly, it was the outcomes of
the women with type 2 diabetes in the
study of Murphy et al. that experienced
statisticallysigniﬁcantimprovementsthat
helped to reduce overall adverse out-
comes (10). For women with type 2 dia-
betes, the congenital malformation rate
fellfrom12.3to4.4%,perinatalmortality
fell from 6.2 to 0.9%, and any serious ad-
verse outcome fell from 16.4 to 5.3%,
whereas in all these subcategories, there
was very little change for women with
type 1 diabetes. The importance of the
reported study is that it shows that access
toprepregnancycounselingandcaredoes
reduce adverse pregnancy outcomes by
about 80% (odds ratio 0.2 [95% CI
0.050.89]; P  0.03) (10).
For women with type 1 diabetes, not
only do we need to improve their use of
and access to prepregnancy care, but we
needtocontinuetoimprovemanagement
techniques to safely achieve levels of glu-
cosecontrolinoureffortstoimproveout-
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the women with diabetes as to how im-
portant their efforts are in learning and
applying self-management techniques in
order to achieve excellent outcomes. As
Dr. Donald R. Coustan suggested in his
editorial in Diabetes Care over 10 years
ago, “the relationship’s the thing.” The
role of the interpersonal relationship be-
tweenthewomanandherhealthcarepro-
vider as well as the strength of her
relationship with her partner and his in-
volvement and understanding play roles
inthesuccessfuloutcomeofpregnancyin
women with diabetes that are difﬁcult to
measure (23).
For women with type 2 diabetes, this
isagrowingproblem,particularlyinareas
of the world where the ethnic risk of type
2 diabetes is higher and access to ade-
quate medical care may be an issue, such
as in India and China (24). Many women
with type 2 diabetes are treated with oral
agents prior to conception, which are
usually prescribed by their family physi-
cian or obstetric-care provider. Any phy-
sician prescribing oral agents, statins,
and/or ACE inhibitors to a woman of
childbearing age must automatically re-
view any potential plans she may have for
pregnancy and remind the woman of the
necessity of planning and adjustments to
hermedicationsshouldshebecomepreg-
nant. It is crucial that prepregnancy coun-
seling becomes an essential part of overall
diabetes management, and primary-care
providers are well aware of the improve-
ment in outcome it provides. It is equally
crucial that women are well acquainted
with their responsibilities in undertaking a
pregnancy in the face of diabetes.
Integration of preconception care
within a larger maternal and child health
continuum of care is consistent with the
Kathmandu Declaration made in 2009,
whichencompassestheconceptofthelife
circle(25).Periconceptioncareofwomen
with diabetes becomes an essential com-
ponentofpreventiveeffortstoavoidmore
diabetesinfuturegenerations(7,25).Pro-
grams like the one reported by Murphy
et al. can make a difference. Based on the
Ohio experience, efforts become more ef-
fective when they occur consistently over
longer periods of time. Successful efforts
toeliminatetherisksinpregnancyandfor
the offspring in women with known dia-
betes will require improvements in and
maintenance of clinical expertise. How-
ever the best health care system available
is of no use unless the customers, in this
casewomenwithdiabetesofreproductive
age, are responsive and responsible.
Clearly, individual women must become
more involved and sensitized to the ne-
cessity and usefulness of preparing ade-
quately for a pregnancy and learning self-
management. This is an ongoing
challenge in the care of diabetes.
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